Sanofi-Aventis UK Pension Scheme

Sanofi-Aventis UK Pension Scheme

The scheme was established in 1998 to provide retirement benefits to UK employees of the Sanofi pharmaceutical group. Its sponsoring employer is Aventis Pharma Limited, a wholly owned subsidiary of the French multinational Sanofi SA. The scheme is managed by Sanofi-Aventis Pensions Trust Limited, a corporate trustee incorporated that same year. The scheme's investment strategy has pivoted decisively toward liability matching. Rather than maintaining an actively managed portfolio of equities and credit, the trustee executed a buy-in with Legal & General, covering all member benefits. This annuitisation approach eliminates longevity, interest-rate, and inflation risk from the scheme's balance sheet, converting the pension promise into a series of insurance policies. Trustee governance rests with a board that includes Dan Parr and Gordon Tillett, the latter appointed in October 2025. Pratul Shah resigned as Company Trustee Director in September 2025. The scheme maintains a lean operating structure, with no disclosed direct investment team, consistent with a fully insured pension that requires no ongoing asset allocation or manager selection. The scheme's structural differentiator is its end-state posture. Unlike open corporate pensions continuously calibrating growth assets against liabilities, the Sanofi-Aventis UK Pension Scheme has completed its de-risking journey. It now functions as an insured arrangement where the sponsor's obligation runs to the premium, not to the investment outcome — a rare fully closed loop in UK defined-benefit pensions.